Support for Research
Research in hematology is critical to improving our understanding of diseases, clinical practice, and overall patient care.
Support for research in hematology is a priority for EHA, including for our European Affairs team.
Together with other medical societies and patient organizations, we advocate for EU-level strategies and collaboration around topics that are now central to the EU’s new policies. These topics include:
- Accessibility and affordability
- Patient-centric, unmet-needs-based development of medicines
- Dedicated regulatory and data frameworks for personalized medicine and rare diseases
You can find out more about our work in this area by reading our position papers.
Relevant EU funding calls for hematology
Horizon Europe
- Capacity building on Intellectual Property (IP) management to support open science (deadline: March 12, 2024)
- Global cooperation in not-for-profit open access publishing (deadline: March 12, 2024)
- Bio-printing of living cells for regenerative medicine (deadline: April 11, 2024)
- Developing EU methodological frameworks for clinical/performance evaluation and post-market clinical/performance follow-up of medical devices and in vitro diagnostic medical devices (IVDs) (deadline: April 11, 2024)
- Gaining experience and confidence in New Approach Methodologies (NAM) for regulatory safety and efficacy testing – coordinated training and experience exchange for regulators (deadline: April 11, 2024)
- MSCA International Cooperation 2024 (deadline: September 4, 2024)
- MSCA Postdoctoral Fellowship 2024 (deadline: September 11, 2024)
- European Partnership: One Health Anti-Microbial Resistance (deadline: September 25, 2024)
- MSCA Researchers at Risk 2024 (deadline: January 14, 2025)
Innovative Health Initiative
- Support healthcare system resilience through a focus on persistency in the treatment of chronic diseases (deadline: April 16, 2024)
- Development of evidence based practical guidance for sponsors on the use of real-world data / real-world evidence (deadline: April 16, 2024)
- Clinical validation of biomarkers for diagnosis, monitoring disease progression and treatment response (deadline: May 22, 2024)
- User-centric technologies and optimized hospital workflows for a sustainable healthcare workforce (deadline: May 22, 2024)